Sun Pharma to Acquire US-Listed Organon in $12 Billion Deal

This is a live story built from multiple sources. It may evolve quickly.

Coverage meter • 1 min window

Back to home Open top source

B bloomberg.com

What’s included

Top recent items from this story.

1 items • 1 unique links

Bloomberg Markets 5 days ago • bloomberg.com

Sun Pharma to Acquire US-Listed Organon in $12 Billion Deal

Sun Pharmaceutical Industries Ltd. agreed to acquire New York-listed women’s health-care company Organon & Co., in what is likely to be one of the biggest India outbound deals in years.

Open